4123 Stock Overview
A pharmaceutical company, engages in the manufacturing and trading of pharmaceuticals in Taiwan and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 2/6 |
| Dividends | 1/6 |
Center Laboratories, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | NT$52.80 |
| 52 Week High | NT$59.60 |
| 52 Week Low | NT$40.80 |
| Beta | 0.85 |
| 11 Month Change | -2.94% |
| 3 Month Change | 21.80% |
| 1 Year Change | -6.09% |
| 33 Year Change | 7.72% |
| 5 Year Change | 10.27% |
| Change since IPO | 1,878.11% |
Recent News & Updates
Shareholder Returns
| 4123 | TW Pharmaceuticals | TW Market | |
|---|---|---|---|
| 7D | -6.4% | -1.6% | -4.6% |
| 1Y | -6.1% | 9.8% | 31.4% |
Return vs Industry: 4123 underperformed the TW Pharmaceuticals industry which returned 9.8% over the past year.
Return vs Market: 4123 underperformed the TW Market which returned 31.4% over the past year.
Price Volatility
| 4123 volatility | |
|---|---|
| 4123 Average Weekly Movement | 5.0% |
| Pharmaceuticals Industry Average Movement | 4.5% |
| Market Average Movement | 4.7% |
| 10% most volatile stocks in TW Market | 8.6% |
| 10% least volatile stocks in TW Market | 2.2% |
Stable Share Price: 4123 has not had significant price volatility in the past 3 months.
Volatility Over Time: 4123's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1959 | n/a | Su-Chi Wang | www.centerlab.com.tw |
Center Laboratories, Inc., a pharmaceutical company, engages in the manufacturing and trading of pharmaceuticals in Taiwan and internationally. It engages in the research and development of small molecule drugs, as well as solutions for neurological and oncological diseases; development of proteins and antibodies; and pharmaceutical CDMO, medical device, software as medical device, nutritional health and agribiotechnology, stem cell and immune cell therapy, and industry investment and venture capital businesses. The company also supplies glass fibre pressure vessels.
Center Laboratories, Inc. Fundamentals Summary
| 4123 fundamental statistics | |
|---|---|
| Market cap | NT$36.23b |
| Earnings (TTM) | -NT$2.53b |
| Revenue (TTM) | NT$1.42b |
25.5x
P/S Ratio-14.3x
P/E RatioIs 4123 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 4123 income statement (TTM) | |
|---|---|
| Revenue | NT$1.42b |
| Cost of Revenue | NT$780.21m |
| Gross Profit | NT$642.20m |
| Other Expenses | NT$3.17b |
| Earnings | -NT$2.53b |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -3.68 |
| Gross Margin | 45.15% |
| Net Profit Margin | -177.73% |
| Debt/Equity Ratio | 31.9% |
How did 4123 perform over the long term?
See historical performance and comparisonDividends
2.8%
Current Dividend Yield-40%
Payout RatioDoes 4123 pay a reliable dividends?
See 4123 dividend history and benchmarks| Center Laboratories dividend dates | |
|---|---|
| Ex Dividend Date | Aug 02 2024 |
| Dividend Pay Date | Aug 30 2024 |
| Days until Ex dividend | 8 days |
| Days until Dividend pay date | 36 days |
Does 4123 pay a reliable dividends?
See 4123 dividend history and benchmarks